Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Lannett Company, Inc. LCI
$0.69
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
7380504.00000000
-
week52high
3.72
-
week52low
0.01
-
Revenue
340579000
-
P/E TTM
0
-
Beta
0.94740400
-
EPS
-19.14000000
-
Last Dividend
0.00000000
-
Next Earnings Date
02 мая 2023 г. в 10:59
Описание компании
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's product portfolio includes Amphetamine IR tablets, Amphetamine ER capsules, Dicyclomine tablets, Fluphenazine tablets, Levothyroxine capsules, Methylphenidate CD capsules, Methylphenidate ER, Posaconazole DR tablets, Probenecid tablets, and Verapamil SR tablets, as well as Numbrino nasal solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, Sinotherapeutics, Respirent Pharmaceuticals Co., Ltd., HEC Pharm Group, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Roth Capital | Neutral | Neutral | 31 авг 2021 г. |
Roth Capital | Neutral | Neutral | 10 июн 2021 г. |
SunTrust Robinson Humphrey | Hold | Hold | 18 сент 2019 г. |
SunTrust Robinson Humphrey | Hold | Hold | 29 авг 2019 г. |
SunTrust Robinson Humphrey | Hold | 20 мар 2019 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Chapman John C | A | 174324 | 20000 | 17 ноя 2022 г. |
Crew Timothy C | A | 604291 | 15000 | 10 ноя 2022 г. |
LEPORE PATRICK G | A | 587145 | 100000 | 10 ноя 2022 г. |
Rewolinski Melissa | A | 93259 | 31159 | 14 сент 2022 г. |
Abt John | D | 118825 | 950 | 07 сент 2022 г. |
KOZLOWSKI JOHN | D | 131798 | 775 | 07 сент 2022 г. |
Cavanaugh Maureen | D | 143896 | 5656 | 31 июл 2022 г. |
Abt John | D | 119775 | 3924 | 31 июл 2022 г. |
KOZLOWSKI JOHN | D | 138954 | 8114 | 31 июл 2022 г. |
Israel Samuel H | D | 156644 | 10154 | 31 июл 2022 г. |
Новостная лента
7 Stocks to Sell as Borrowing Costs Rise
InvestorPlace
28 февр 2023 г. в 14:46
With major economic weakness possibly lurking around the corner, investors should consider targeting stocks to sell. Specifically, market participants should note securities that feature rising short borrow fees.
Lannett Company, Inc. (LCI) Q2 2023 Earnings Call Transcript
Seeking Alpha
01 февр 2023 г. в 21:06
Lannett Company, Inc. (NYSE:LCI ) Q2 2023 Earnings Conference Call February 1, 2023 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Tim Crew - Chief Executive Officer John Kozlowski - Chief Financial Officer Operator Greetings and welcome to the Lannett Company Fiscal 2023 Second Quarter Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Lannett (LCI) Reports Q2 Loss, Tops Revenue Estimates
Zacks Investment Research
01 февр 2023 г. в 20:19
Lannett (LCI) delivered earnings and revenue surprises of 17.07% and 10.84%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Lannett Company, Inc. (LCI) Q1 2023 Earnings Call Transcript
Seeking Alpha
02 ноя 2022 г. в 19:14
Lannett Company, Inc. (NYSE:LCI ) Q1 2023 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Tim Crew - Chief Executive Officer John Kozlowski - Chief Financial Officer Conference Call Participants Scott Henry - ROTH Capital Operator Thank you for standing by. This is the conference operator.
LANNETT TO REPORT FISCAL 2023 FIRST-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, NOVEMBER 2
PRNewsWire
26 окт 2022 г. в 06:52
TREVOSE, Pa. , Oct. 26, 2022 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2023 first quarter on Wednesday, November 2, 2022, after the market closes.